Atrial Fibrillation Trial, Recruiting (NCT07320560)

Atrial Fibrillation Trial, Recruiting NCT07320560 Sponsor: German Heart Institute Condition: Atrial Fibrillation

Printed from Voxsanity (voxsanity.com.au) — NCT07320560 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Atrial Fibrillation

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have persistent atrial fibrillation (an irregular heart rhythm that doesn't stop on its own) and have not previously had a catheter ablation procedure for it, and are now planned to have one
People whose left atrium (one of the heart's chambers) is enlarged, as measured by any one of three specific heart imaging measurements (confirm with trial site for exact measurement details)

Who may not be able to join:

People who have previously had a heart ablation procedure of any kind
People under 18 years of age
People who are pregnant or breastfeeding
People who have previously had a stroke or a mini-stroke (also called a TIA or transient ischaemic attack)
People whose heart's main pumping chamber is working significantly below normal levels (a condition called severe left ventricular dysfunction)
People with serious kidney disease where the kidneys are filtering at a very low level
People with a skin condition or known skin sensitivity that could cause skin irritation or a rash

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Till F Althoff, M.D., German Heart Center of the Charitè, Berlin, Department of Cardiology, Angiology and Intensive Care Medicine

Phone: 0049 30 450613163

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07320560

Sponsor: German Heart Institute

Phase: Not Applicable

Status: Recruiting

Condition: Atrial Fibrillation

Trial contact: 0049 30 450613163

More information: https://clinicaltrials.gov/study/NCT07320560

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have persistent atrial fibrillation (an irregular heart rhythm that doesn't stop on its own) and have not previously had a catheter ablation procedure for it, and are now planned to have one
People whose left atrium (one of the heart's chambers) is enlarged, as measured by any one of three specific heart imaging measurements (confirm with trial site for exact measurement details)

Who may not be able to join:

People who have previously had a heart ablation procedure of any kind
People under 18 years of age
People who are pregnant or breastfeeding
People who have previously had a stroke or a mini-stroke (also called a TIA or transient ischaemic attack)
People whose heart's main pumping chamber is working significantly below normal levels (a condition called severe left ventricular dysfunction)
People with serious kidney disease where the kidneys are filtering at a very low level
People with a skin condition or known skin sensitivity that could cause skin irritation or a rash

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

German Heart Institute

Registry

ClinicalTrials.gov

Start date

15 January 2026

Est. completion

31 December 2026

Where this trial is recruiting

🇩🇪 Germany 🇵🇹 Portugal 🇪🇸 Spain

Primary endpoints

Rate of acute AF termination

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov